Dorcas Lamounier Costa1,2, Regina Lunardi Rocha3, Eldo de Brito Ferreira Chaves2, Vivianny Gonçalves de Vasconcelos Batista2, Henrique Lamounier Costa4, Carlos Henrique Nery Costa2,5. 1. Departamento Materno-Infantil, Universidade Federal do Piauí, Teresina, Piauí, Brazil. 2. Instituto de Doenças Tropicais Natan Portella, Teresina, Piauí, Brazil. 3. Departamento de Pediatria, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil. 4. Departamento de Engenharia de Produção, Universidade Federal do Piauí, Teresina, Piauí, Brazil. 5. Departamento de Medicina Comunitária, Universidade Federal do Piauí, Teresina, Piauí, Brazil.
Abstract
INTRODUCTION: Early identification of patients at higher risk of progressing to severe disease and death is crucial for implementing therapeutic and preventive measures; this could reduce the morbidity and mortality from kala-azar. We describe a score set composed of four scales in addition to software for quick assessment of the probability of death from kala-azar at the point of care. METHODS: : Data from 883 patients diagnosed between September 2005 and August 2008 were used to derive the score set, and data from 1,031 patients diagnosed between September 2008 and November 2013 were used to validate the models. Stepwise logistic regression analyses were used to derive the optimal multivariate prediction models. Model performance was assessed by its discriminatory accuracy. A computational specialist system (Kala-Cal(r)) was developed to speed up the calculation of the probability of death based on clinical scores. RESULTS: : The clinical prediction score showed high discrimination (area under the curve [AUC] 0.90) for distinguishing death from survival for children ≤2 years old. Performance improved after adding laboratory variables (AUC 0.93). The clinical score showed equivalent discrimination (AUC 0.89) for older children and adults, which also improved after including laboratory data (AUC 0.92). The score set also showed a high, although lower, discrimination when applied to the validation cohort. CONCLUSIONS: : This score set and Kala-Cal(r) software may help identify individuals with the greatest probability of death. The associated software may speed up the calculation of the probability of death based on clinical scores and assist physicians in decision-making.
INTRODUCTION: Early identification of patients at higher risk of progressing to severe disease and death is crucial for implementing therapeutic and preventive measures; this could reduce the morbidity and mortality from kala-azar. We describe a score set composed of four scales in addition to software for quick assessment of the probability of death from kala-azar at the point of care. METHODS: : Data from 883 patients diagnosed between September 2005 and August 2008 were used to derive the score set, and data from 1,031 patients diagnosed between September 2008 and November 2013 were used to validate the models. Stepwise logistic regression analyses were used to derive the optimal multivariate prediction models. Model performance was assessed by its discriminatory accuracy. A computational specialist system (Kala-Cal(r)) was developed to speed up the calculation of the probability of death based on clinical scores. RESULTS: : The clinical prediction score showed high discrimination (area under the curve [AUC] 0.90) for distinguishing death from survival for children ≤2 years old. Performance improved after adding laboratory variables (AUC 0.93). The clinical score showed equivalent discrimination (AUC 0.89) for older children and adults, which also improved after including laboratory data (AUC 0.92). The score set also showed a high, although lower, discrimination when applied to the validation cohort. CONCLUSIONS: : This score set and Kala-Cal(r) software may help identify individuals with the greatest probability of death. The associated software may speed up the calculation of the probability of death based on clinical scores and assist physicians in decision-making.
Authors: Priscilla Elias Ferreira da Silva; Gerson Dos Santos Fonseca Junior; Roberta Bianchi Ambrozio; Monique Gomes Salles Tiburcio Costa; Gabrielly Borges Machado; Silvio Fernando Guimarães de Carvalho; Edward José de Oliveira; David Calhau Jorge; Luciana de Almeida Silva Teixeira Journal: Am J Trop Med Hyg Date: 2020-06-25 Impact factor: 2.345
Authors: Lays G S Bomfim; Lucas S Magalhães; Marcello A A Santos-Filho; Nalu T A Peres; Cristiane B Corrêa; Diego M Tanajura; Angela M Silva; Michael W Lipscomb; Valéria M Borges; Amélia R Jesus; Roque P Almeida; Tatiana R de Moura Journal: Front Microbiol Date: 2017-11-16 Impact factor: 5.640
Authors: João Gabriel Guimarães Luz; Danilo Bueno Naves; Amanda Gabriela de Carvalho; Gilvani Alves Meira; João Victor Leite Dias; Cor Jesus Fernandes Fontes Journal: Rev Inst Med Trop Sao Paulo Date: 2018-03-08 Impact factor: 1.846
Authors: Ana Nilce S Maia-Elkhoury; Gustavo Adolfo Sierra Romero; Samantha Y O B Valadas; Marcia L Sousa-Gomes; José Angelo Lauletta Lindoso; Elisa Cupolillo; Jose Antonio Ruiz-Postigo; Daniel Argaw; Manuel J Sanchez-Vazquez Journal: PLoS Negl Trop Dis Date: 2019-12-19
Authors: Juliana Foinquinos; Maria do Carmo Duarte; Jose Natal Figueiroa; Jailson B Correia; Nara Vasconcelos Cavalcanti Journal: J Trop Med Date: 2021-12-22
Authors: Lucas Edel Donato; Lúcia Rolim Santana de Freitas; Elisabeth Carmen Duarte; Gustavo Adolfo Sierra Romero Journal: Rev Soc Bras Med Trop Date: 2020-09-11 Impact factor: 1.581